Search Results 1791-1800 of 21494 for birth control

  1. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

    Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for 4 months after the last dose. If you think ...

  2. Publications - Bjorg Thorsteinsdottir, M.D. - Mayo Clinic

    Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities. Curr Hypertens ...

  3. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Hormonal (birth control pill, injections, implants);; Bilateral tubal ligation;; Successful vasectomy. Agree to abstain from breastfeeding during study ...

  4. Reflex Responses to Intermittent Hypoxia in Humans - Mayo Clinic

    Taking no medications (except birth control or at the discretion of the principle investigator). Exclusion Criteria: Not meeting above criteria. Participating ...

  5. Synucleinopathies - Mayo Clinic

    Pregnant or breastfeeding women, and women of childbearing potential who do not practice an acceptable method of birth control. Participants with a ...

  6. Denosumab-bnht (subcutaneous route) - Side effects & uses - Mayo Clinic

    Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for 5 months after the last dose. If you think ...

  7. Elivaldogene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Male patients with female partners should use an effective form of birth control before having a procedure to collect your blood and for at least 6 months after ...

  8. UBX1325 for Treatment of Neovascular ARMD - Mayo Clinic

    Female patients who are pregnant, lactating, or of childbearing potential who do not agree to use highly effective methods of birth control (e.g. ...

  9. Velmanase alfa-tycv (intravenous route) - Side effects & uses - Mayo Clinic

    Use an effective form of birth control during treatment with this medicine and for 14 days after the last dose to keep from getting pregnant. Tell your ...

  10. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    Subjects of child-bearing potential who are not willing to practice birth control from the time of consent through 6 months after the administration of ...